Tabula Rasa HealthCare’s (TRHC) OnDemand webinars are available from October 19, 2018 – December 17, 2018. These recordings are from TRHC’s well-received continuing education (CE) live sessions that took place in September 2018 in Minnesota and Iowa. There is no cost to participate in these OnDemand webinars. Participants will receive up to 2 hours of CE credits.
This activity is intended for physicians, nurses, pharmacists, and pharmacy technicians engaged in the care of all patients in the outpatient setting.
CE-Accredited Educational Objectives
After completing the activity, Opioid Pharmacology and Drug Interactions Affecting Opioid Response, participants should be better able to:
After completing the activity, Case Discussion: Multi-drug Interactions in Patients with Polypharmacy, participants should be better able to:
After the Enhanced Medication Therapy Management (EMTM) activity, participants should be better able to:
Sr. Vice President, Research & Development, TRHC
President, Iverson Corner Drug, Inc.
EMTM Lead, ClearStone Solutions
Director of Clinical Initiatives, Towncrest Pharmacy
Co-Owner, Towncrest Pharmacy
Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the providership of Tabula Rasa HealthCare, Inc. TRHC is accredited by the ACCME to provide continuing medical education for physicians.
TRHC designates this live activity for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Pharmacy Education
TRHC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Opioid Pharmacology and Drug Interactions Affecting Opioid Response
TRHC designates this continuing education activity for 1 contact hours (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Case Discussion: Multi-Drug Interactions in Patients with Polypharmacy
TRHC designates this continuing education activity for 1 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Nursing Education
Tabula Rasa HealthCare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This educational activity for 2 contact hour(s) is provided by TRHC.
Disclosure of Conflicts of Interest
TRHC requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to TRHC policy. TRHC is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty members have nothing to disclose.
Planners and Managers
The TRHC planners and managers have nothing to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Request for Credit
A statement of credit may be downloaded within the webinar console upon successful viewing of the video, the post-test, and activity evaluation form.
Pharmacists: Upon completion of the activity evaluation, your transcript information will be sent to the NABP CPE Monitor Service.